proline has been researched along with Trigeminal Neuralgia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bockbrader, H; Chapel, S; Cleall, S; Forrestal, F; Naik, H; Zhao, Y | 1 |
Cruccu, G; Di Stefano, G; Truini, A | 1 |
Obermann, M | 1 |
Ettlin, DA; Giblin, GM; Gunn, K; Morisset, V; Obermann, M; Palmer, J; Tate, S; Zakrzewska, JM | 1 |
Bendtsen, L; Cruccu, G; Derjean, D; Estacion, M; Ettlin, DA; Giblin, GM; Gunn, K; Layton, G; Morisset, V; Obermann, M; Palmer, J; Tate, S; Waxman, SG; Zakrzewska, JM | 1 |
3 review(s) available for proline and Trigeminal Neuralgia
Article | Year |
---|---|
Population Pharmacokinetics of Vixotrigine in Healthy Volunteers and Subjects with Trigeminal Neuralgia, Painful Lumbosacral Radiculopathy and Erythromelalgia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Asian People; Biological Availability; Erythromelalgia; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Models, Biological; Phenyl Ethers; Proline; Radiculopathy; Tissue Distribution; Trigeminal Neuralgia; Voltage-Gated Sodium Channel Blockers; Young Adult | 2021 |
Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.
Topics: Anticonvulsants; Antidepressive Agents; Baclofen; Carbamazepine; Drug Therapy, Combination; Gabapentin; Humans; Lamotrigine; Oxcarbazepine; Phenyl Ethers; Proline; Sodium Channel Blockers; Trigeminal Neuralgia | 2018 |
Recent advances in understanding/managing trigeminal neuralgia.
Topics: Carbamazepine; Humans; Phenyl Ethers; Proline; Quality of Life; Radiosurgery; Sodium Channel Blockers; Transcranial Direct Current Stimulation; Trigeminal Neuralgia | 2019 |
2 trial(s) available for proline and Trigeminal Neuralgia
Article | Year |
---|---|
Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia.
Topics: Double-Blind Method; Humans; Outcome Assessment, Health Care; Phenyl Ethers; Proline; Research Design; Sodium Channel Blockers; Trigeminal Neuralgia; Withholding Treatment | 2013 |
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
Topics: Adult; Aged; Area Under Curve; Double-Blind Method; Electrocardiography; Female; Humans; International Cooperation; Kaplan-Meier Estimate; Male; Middle Aged; Phenyl Ethers; Proline; Retrospective Studies; Sodium Channel Blockers; Treatment Outcome; Trigeminal Neuralgia; Young Adult | 2017 |